Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Strategic Research Collaboration

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge

Parkinson's Disease Research

Gb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of Lethbridge

Gb Sciences, Inc.

PR-M04-22-08April 12, 2022

BigHat Biosciences Completes First Stage of Research Collaboration With Amgen

Research Collaboration

BigHat Biosciences Completes First Stage of Research Collaboration With Amgen

BigHat Biosciences, Inc.

PR-M01-22-08January 11, 2022

The COVID-19 Vaccine Journey Continues

COVID-19 Vaccines

The COVID-19 Vaccine Journey Continues

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-05-21-NI-02May 13, 2021

XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery

Drug Discovery

XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery

XtalPi Inc.

PR-M05-18-NI-041May 10, 2018